Dr. Anthony Fauci addresses J&J vaccine pause — ‘This is a very rare event’
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, and Jeff Zients of the White House
Read more
Business News
Fighting fertility misinformation on Covid-19 vaccine
Scientists say there’s no evidence that supports the claim that coronavirus vaccines will cause infertility. Public health officials are trying
Read more
Wharton professor on the employer Covid vaccine requirement dilemma
Nancy Rothbard, chair of the Management Department at the University of Pennsylvania’s Wharton School, joined “Squawk Box” on Thursday to
Read more
Jim Cramer: Positive Pfizer vaccine trial takes ‘impending doom’ off the table
CNBC’s “Squawk on the Street” team discusses the news that Pfizer’s Covid vaccine appears to be 100% effective in 12-
Read more
AstraZeneca vaccine found to be 79% effective in U.S. trial
The findings of a large U.S. trial have shown that the coronavirus vaccine developed by AstraZeneca and the University of
Read more
Pfizer vaccine neutralizes Brazil and U.K. variants of Covid-19: Lab study
There’s new optimism surrounding Pfizer’s coronavirus vaccine’s ability to fight against the rapidly spreading new variants. CNBC’s Meg Tirrell reports.
Read more
Pfizer: South African variant could significantly reduce vaccine protection
A new study shows the neutralization levels against the South African covid variant were two-thirds lower when compared to the
Read more
Joe Biden administration plans to buy 200M more Covid-19 vaccine doses
Kayla Tausche reports senior administration officials said they plan to give states a 3-week window into vaccine allotments as they
Read more
Pfizer CEO Albert Bourla on Covid-19 vaccine manufacturing outlook
Pfizer CEO Albert Bourla told CNBC’s “Squawk Box” Tuesday that the company plans to increase coronavirus vaccine production this year,
Read more
Former FDA chief on Pfizer Covid-19 vaccine’s ability to neutralize variants
A coronavirus vaccine developed by Pfizer and BioNTech appears to be effective against a key mutation in the more infectious
Read more